© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Eloxx Pharmaceuticals, Inc. (ELOX) shows an Average True Range (ATR) of N/A and an Enterprise Value of N/A. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into ELOX's underlying financial health and market activity.
| ATR | N/A |
| Enterprise Value | - |
| Avg Vol (3 Months) | - |
| Avg Vol (10 Days) | - |
Eloxx Pharmaceuticals, Inc. (ELOX) technical indicators as of June 19, 2026: the SMA 20 is N/A, SMA 50 at N/A, and SMA 200 at N/A. The RSI 14 value is N/A, suggesting its current momentum. These technical analysis signals help assess ELOX's price trends and potential future movements.
| SMA 20 | N/A |
| SMA 50 | N/A |
| SMA 200 | N/A |
| RSI 14 | N/A |
Eloxx Pharmaceuticals, Inc. (ELOX) stock performance overview as of June 19, 2026: The 52-week high is $17.5 (currently N/A below), and the 52-week low is $0.001 (currently N/A above). Over the past year, ELOX's performance is -79.1%, compared to the S&P 500's 10.43% change.
| 52-Week High | 17.5 |
| 52-Week High Chg | - |
| 52-Week Low | 0.001 |
| 52-Week Low Chg | - |
| S&P 500 52-Week Chg | 10.43% |
According to market data, Eloxx Pharmaceuticals, Inc. (ELOX) stock's recent performance metrics show that over the last month, ELOX is 8.92%, with a Year-to-Date (YTD) performance of -27.39%. Over the past year, the stock has seen a -79.1% change. These figures summarize ELOX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 17.5 | 17.5 | 17.5 | 17.5 | 17.5 | 17.5 |
| Low | 11.4 | 0.238 | 0.001 | 0.001 | 0.001 | 0.001 |
| Performance | -18.57% | +8.92% | -48.13% | -85.43% | -79.10% | -27.39% |
According to current financial data, ELOX stock's P/E (TTM) ratio is -11.21, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for ELOX, including P/S (N/A), P/B (-8.08), and P/FCF (-24.92), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ELOX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -11.21 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | -8.08 | 13.62 | 11.12 | 5.05 |
| P/FCF (TTM) | -24.92 | -7.13 | -912.15 | 28.57 |